455PDFirst-in-human, first-in-class phase I study of MTL-CEBPA, a RNA oligonucleotide targeting the myeloid cell master regulator C/EBP-α, in patients with advanced hepatocellular cancer (HCC)
Sarker, D, Plummer, R, Basu, B, Meyer, T, MA, Y -T, Evans, J, Palmer, D H, Huang, K -W, Chee, C E, Spalding, D, Sodergren, M, Habib, NVolume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz244.017
Date:
October, 2019
Fichier:
PDF, 86 KB
2019
File converter
Plus de résultats de recherche
More benefits 
